Treatment with somatostatin analogs induces differentially expressed let-7c-5p and mir-3137 in small intestine neuroendocrine tumors

MLA

Florian Bösch, et al. “Treatment with Somatostatin Analogs Induces Differentially Expressed Let-7c-5p and Mir-3137 in Small Intestine Neuroendocrine Tumors.” BMC Cancer, vol. 19, no. 1, June 2019, pp. 1–8. EBSCOhost, https://doi.org/10.1186/s12885-019-5794-y.

APA

Florian Bösch, Alexandr V. Bazhin, Sabine Heublein, Katharina Brüwer, Thomas Knösel, Florian P. Reiter, Christoph J. Auernhammer, Markus O. Guba, Christine Spitzweg, Jens Werner, & Martin K. Angele. (2019). Treatment with somatostatin analogs induces differentially expressed let-7c-5p and mir-3137 in small intestine neuroendocrine tumors. BMC Cancer, 19(1), 1–8. https://doi.org/10.1186/s12885-019-5794-y

Chicago

Florian Bösch, Alexandr V. Bazhin, Sabine Heublein, Katharina Brüwer, Thomas Knösel, Florian P. Reiter, Christoph J. Auernhammer, et al. 2019. “Treatment with Somatostatin Analogs Induces Differentially Expressed Let-7c-5p and Mir-3137 in Small Intestine Neuroendocrine Tumors.” BMC Cancer 19 (1): 1–8. doi:10.1186/s12885-019-5794-y.